Abstract
Therapeutic options for patients with isolated severe to torrential tricuspid regurgitation have been limited. Because a surgical option is often not attractive, new catheter-based therapies are emerging. We report the first-in-human percutaneous transcatheter tricuspid valve replacement with the MonarQ system in a 75-year-old female patient with severely symptomatic torrential tricuspid regurgitation. (Level of Difficulty: Advanced.).
Originalsprog | Engelsk |
---|---|
Artikelnummer | 101841 |
Tidsskrift | JACC: Case Reports |
Vol/bind | 14 |
Sider (fra-til) | 1-7 |
Antal sider | 7 |
DOI | |
Status | Udgivet - 17 maj 2023 |